Muzz Forget the 75 m in the bank If you take the 5 m charge and...

Muzz
Forget the 75 m in the bank
If you take the 5 m charge and look at the fact that operating expenses would reduce by 8 million from next year one must assume they are at least double that now . I think the cash will downsize to about 55-60m and any new drug will come with a CR .there is no doubt they will buy something to justify their existence

I can't help but think that within the industry , despite the story we were sold , RP may not have been a rockstar but rather on the nose for offloading a failed drug. Different to develop a drug and be TO to selling a drug for billions that ends up a dud - my opinion only